AN2 Therapeutics, Inc.【ANTX】Cash flow
Market cap
$141.52M
P/E ratio
| 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 4 | 8 | 8 |
| Cash from operations | -33 | -53 | -49 |
| Cash from investing | -22 | -43 | 55 |
| Cash from financing | 70 | 85 | 0 |
| 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 4 | 8 | 8 |
| Cash from operations | -33 | -53 | -49 |
| Cash from investing | -22 | -43 | 55 |
| Cash from financing | 70 | 85 | 0 |